611169412	611169412	CD	B-NP	O
|	|	NN	I-NP	O
TH	TH	NN	I-NP	O
|	|	NN	I-NP	O
40069618	40069618	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
2027166	2027166	CD	B-NP	O
|	|	CC	I-NP	O
4/10/2004	4/10/2004	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CHRONIC	CHRONIC	NNP	I-NP	I-protein
OBSTRUCTIVE	OBSTRUCTIVE	NNP	I-NP	I-protein
PULMONARY	PULMONARY	NNP	I-NP	I-protein
DISEASE	DISEASE	NNP	I-NP	I-protein
EXACERBATION	EXACERBATION	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/10/2004	2/10/2004	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/23/2004	6/23/2004	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
RAYMUNDO	RAYMUNDO	NN	B-NP	O
RODRIUEZ	RODRIUEZ	NN	I-NP	O
MD	MD	NN	I-NP	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
60-year-old	60-year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
obstructive	obstructive	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
disease	disease	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
FEV1	FEV1	NN	I-NP	O
of	of	IN	B-PP	O
0.42	0.42	CD	B-NP	O
,	,	,	O	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
with	with	IN	B-PP	O
ejection	ejection	NN	B-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
40	40	CD	I-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
from	from	IN	B-PP	O
Bradpark	Bradpark	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
for	for	IN	B-PP	O
continued	continued	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
for	for	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
reports	report	VBZ	B-VP	O
that	that	IN	B-SBAR	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
admission	admission	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Daspe	Daspe	NNP	I-NP	O
I	I	NNP	I-NP	O
Health	Health	NNP	I-NP	O
,	,	,	O	O
two	two	CD	B-NP	O
days	day	NNS	I-NP	O
before	before	IN	B-PP	O
transfer	transfer	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Ordma	Ordma	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
felt	feel	VBD	B-VP	O
more	more	RBR	B-ADJP	O
dyspneic	dyspneic	JJ	I-ADJP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
noted	note	VBD	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
having	have	VBG	I-VP	O
a	a	DT	B-NP	O
hard	hard	JJ	I-NP	O
time	time	NN	I-NP	O
even	even	RB	B-VP	O
getting	get	VBG	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
bathroom	bathroom	NN	I-NP	O
.	.	.	O	O

Ordinarily	Ordinarily	RB	B-ADVP	O
,	,	,	O	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
using	use	VBG	B-VP	O
1.5	1.5	CD	B-NP	O
liters	liter	NNS	I-NP	O
of	of	IN	B-PP	O
oxygen	oxygen	NN	B-NP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
get	get	VB	I-VP	O
around	around	IN	B-PP	O
the	the	DT	B-NP	O
house	house	NN	I-NP	O
and	and	CC	I-NP	O
upstairs	upstairs	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
went	go	VBD	B-VP	O
to	to	TO	B-PP	O
Lahorn	Lahorn	NNP	B-NP	O
Mulg	Mulg	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
on	on	IN	B-PP	O
Sunday	Sunday	NNP	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
reports	report	VBZ	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
dry	dry	JJ	I-NP	O
cough	cough	NN	I-NP	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
sputum	sputum	NN	I-NP	O
production	production	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
fever	fever	NN	I-NP	O
or	or	CC	I-NP	O
chills	chill	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
sick	sick	JJ	I-NP	O
contacts	contact	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
hemoptysis	hemoptysis	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
runny	runny	JJ	I-NP	O
nose	nose	NN	I-NP	O
or	or	CC	I-NP	O
sore	sore	NN	I-NP	O
throat	throat	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
different	different	JJ	B-ADJP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
usual	usual	JJ	I-NP	O
COPD	COPD	NN	I-NP	O
excerebration	excerebration	NN	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
no	no	RB	B-ADVP	O
longer	longer	RBR	I-ADVP	O
proceeded	proceed	VBN	B-VP	O
by	by	IN	B-PP	O
symptoms	symptom	NNS	B-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
upper	upper	JJ	I-NP	O
respiratory	respiratory	JJ	I-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
history	history	NN	I-NP	O
reveals	reveal	VBZ	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
usually	usually	RB	B-ADVP	O
uses	use	VBZ	B-VP	O
two	two	CD	B-NP	O
pillows	pillow	NNS	I-NP	O
to	to	TO	B-VP	O
sleep	sleep	VB	I-VP	O
,	,	,	O	O
but	but	CC	O	O
recently	recently	RB	B-ADVP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
using	use	VBG	I-VP	O
two	two	CD	B-NP	O
pillows	pillow	NNS	I-NP	O
folded	fold	VBD	B-VP	O
and	and	CC	O	O
felt	feel	VBD	B-VP	O
short	short	RB	B-ADVP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
if	if	IN	B-SBAR	O
she	she	PRP	B-NP	O
lay	lie	VBD	B-VP	O
down	down	RB	B-ADJP	O
more	more	JJR	I-ADJP	O
than	than	IN	B-PP	O
that	that	DT	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
would	would	MD	B-VP	O
wakeup	wakeup	VB	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
middle	middle	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
night	night	NN	I-NP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
short	short	JJ	B-ADJP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
that	that	DT	B-NP	O
symptom	symptom	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
previous	previous	JJ	I-NP	O
months	month	NNS	I-NP	O
.	.	.	O	O

REVIEW	REVIEW	NNP	B-NP	O
OF	OF	IN	B-PP	O
SYSTEMS	SYSTEMS	NNP	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
gained	gain	VBN	I-VP	O
15	15	CD	B-NP	O
pounds	pound	NNS	I-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
year	year	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
believes	believe	VBZ	B-VP	O
that	that	IN	B-SBAR	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
previous	previous	JJ	B-NP	O
steroid	steroid	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
notes	note	VBZ	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
some	some	DT	B-NP	O
diarrhea	diarrhea	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
``	``	``	O	O
like	like	IN	B-PP	O
pudding	pudde	VBG	B-VP	O
''	''	''	O	O
1-3	1-3	CD	B-NP	O
times	time	NNS	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
.	.	.	O	O

Not	Not	RB	B-NP	O
watery	watery	NN	I-NP	O
,	,	,	O	O
not	not	RB	B-ADJP	O
bloody	bloody	JJ	I-ADJP	O
,	,	,	B-NP	O
and	and	CC	I-NP	O
not	not	RB	I-NP	O
black	black	JJ	B-ADJP	O
.	.	.	O	O

No	No	DT	B-NP	O
recent	recent	JJ	I-NP	O
antibiotic	antibiotic	JJ	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
an	an	DT	B-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
aminophyllin	aminophyllin	NN	B-NP	B-protein
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
hypotension	hypotension	NN	B-NP	O
and	and	CC	I-NP	O
arrhythmias	arrhythmia	NNS	I-NP	O
from	from	IN	B-PP	O
that	that	DT	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
reaction	reaction	NN	I-NP	O
to	to	TO	B-PP	O
beta-blockers	beta-blocker	NNS	B-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
worsening	worsen	VBG	I-VP	O
breathing	breathing	NN	B-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

COPD	COPD	NN	B-NP	O
in	in	IN	B-PP	O
August	August	NNP	B-NP	O
,	,	,	O	O
2004	2004	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
FEV1	FEV1	NN	I-NP	O
of	of	IN	B-PP	O
0.42	0.42	CD	B-NP	O
and	and	CC	O	O
FVC	FVC	NN	B-NP	O
of	of	IN	B-PP	O
1.95	1.95	CD	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Congestive	Congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
April	April	NNP	B-NP	O
2003	2003	CD	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
40	40	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
inferior	inferior	JJ	B-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
ventricle	ventricle	NN	I-NP	O
is	be	VBZ	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
mild	mild	JJ	B-NP	O
aortic	aortic	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
mitral	mitral	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
atria	atrium	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
normal	normal	JJ	B-NP	O
tricuspid	tricuspid	JJ	I-NP	O
valve	valve	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Cerebrovascular	Cerebrovascular	JJ	B-NP	O
accident	accident	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Type	Type	NN	B-NP	O
II	II	CD	I-NP	O
diabetes	diabete	NNS	I-NP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
takes	take	VBZ	B-VP	O
steroids	steroid	NNS	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Osteoarthritis	Osteoarthritis	NN	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Gastroesophageal	Gastroesophageal	JJ	B-NP	O
reflux	reflux	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Depression	Depression	NN	B-NP	O
and	and	CC	I-NP	O
anxiety	anxiety	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Advair	Advair	NN	B-NP	O
250/50	250/50	CD	I-NP	O
mg	mg	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Albuterol	Albuterol	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Atacand	Atacand	NN	B-NP	O
4	4	CD	I-NP	O
mg	mg	NN	I-NP	O
each	each	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Celexa	Celexa	NN	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
each	each	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Clonazepam	Clonazepam	NN	B-NP	O
0.5	0.5	CD	I-NP	O
mg	mg	NN	I-NP	O
two	two	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Coumadin	Coumadin	NN	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
on	on	IN	B-PP	O
Monday	Monday	NNP	B-NP	O
and	and	CC	O	O
Sunday	Sunday	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
5	5	CD	B-NP	O
mg	mg	NN	I-NP	O
on	on	IN	B-PP	O
other	other	JJ	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Enteric-coated	Enteric-coated	JJ	B-NP	O
aspirin	aspirin	NN	I-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Folate	Folate	NN	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Fosamax	Fosamax	NN	B-NP	O
70	70	CD	I-NP	O
mg	mg	NN	I-NP	O
per	per	IN	B-PP	O
week	week	NN	B-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Lasix	Lasix	NN	B-NP	O
40-60	40-60	CD	I-NP	O
mg	mg	NN	I-NP	O
each	each	DT	B-NP	O
morning	morning	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
not	not	RB	I-VP	O
been	be	VBN	I-VP	O
taking	take	VBG	I-VP	O
because	because	IN	B-SBAR	O
it	it	PRP	B-NP	O
made	make	VBD	B-VP	O
her	her	PRP	B-NP	O
pee	pee	VB	B-VP	O
too	too	RB	B-NP	O
much	much	JJ	I-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Atrovent	Atrovent	JJ	B-NP	O
inhaler	inhaler	NN	I-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Ritalin	Ritalin	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
every	every	DT	B-NP	O
morning	morning	NN	I-NP	O
and	and	CC	B-PP	O
at	at	IN	B-PP	O
lunch	lunch	NN	B-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
she	she	PRP	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
feel	feel	VB	I-VP	O
that	that	IN	B-SBAR	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
benefiting	benefit	VBG	I-VP	O
her	her	PRP	B-NP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Prilosec	Prilosec	RB	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

14	14	CD	B-NP	O
.	.	.	O	O

Probenecid	Probenecid	NN	B-NP	O
250	250	CD	I-NP	O
mg	mg	NN	I-NP	O
two	two	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

15	15	CD	B-NP	O
.	.	.	O	O

Tylenol	Tylenol	NN	B-NP	O
No.	No.	NN	I-NP	O
3	3	CD	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

16	16	CD	B-NP	O
.	.	.	O	O

Vioxx	Vioxx	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
each	each	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

17	17	CD	B-NP	O
.	.	.	O	O

Home	Home	NN	B-NP	O
oxygen	oxygen	NN	I-NP	O
1.5	1.5	CD	B-NP	O
liters	liter	NNS	I-NP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Vital	Vital	JJ	B-NP	O
signs	sign	NNS	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	O
was	be	VBD	B-VP	O
96.4	96.4	CD	B-NP	O
degrees	degree	NNS	I-NP	O
Fahrenheit	Fahrenheit	NN	I-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
was	be	VBD	B-VP	O
120	120	CD	B-NP	O
and	and	CC	O	O
regular	regular	JJ	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
142/60	142/60	CD	B-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
was	be	VBD	B-VP	O
24	24	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
sating	sate	VBG	B-VP	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
of	of	IN	B-PP	O
nasal	nasal	JJ	B-NP	O
cannula	cannula	NN	I-NP	O
.	.	.	O	O

General	General	NNP	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
talking	talk	VBG	I-VP	O
2-3	2-3	CD	B-NP	O
words	word	NNS	I-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
can	can	MD	B-VP	O
not	not	RB	I-VP	O
speak	speak	VB	I-VP	O
in	in	IN	B-PP	O
full	full	JJ	B-NP	O
sentences	sentence	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
using	use	VBG	I-VP	O
accessory	accessory	JJ	B-NP	O
muscles	muscle	NNS	I-NP	O
for	for	IN	B-PP	O
breathing	breathing	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
jugular	jugular	JJ	I-NP	O
venous	venous	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
,	,	,	O	O
but	but	CC	O	O
with	with	IN	B-PP	O
significant	significant	JJ	B-NP	O
respiratory	respiratory	JJ	I-NP	O
phasic	phasic	JJ	I-NP	O
variation	variation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
hand	hand	NN	I-NP	O
veins	vein	NNS	I-NP	O
also	also	RB	B-ADVP	O
revealed	reveal	VBD	B-VP	O
an	an	DT	B-NP	O
increased	increase	VBN	I-NP	O
venous	venous	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
pallor	pallor	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
jaundice	jaundice	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
extraocular	extraocular	JJ	I-NP	O
motions	motion	NNS	I-NP	O
were	be	VBD	B-VP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
pupils	pupil	NNS	I-NP	O
were	be	VBD	B-VP	O
equal	equal	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
reactive	reactive	JJ	I-ADJP	O
to	to	TO	B-PP	O
light	light	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
oropharynx	oropharynx	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
thrush	thrush	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
tongue	tongue	NN	I-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
exam	exam	NN	I-NP	O
:	:	:	O	O
There	There	EX	B-NP	O
were	be	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
breath	breath	NN	B-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
were	be	VBD	B-VP	O
soft	soft	JJ	B-NP	O
and	and	CC	I-NP	O
expiratory	expiratory	JJ	I-NP	O
wheezes	wheeze	NNS	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
bases	base	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
crackles	crackle	NNS	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
rhonchi	rhonchi	NN	I-NP	O
.	.	.	O	O

Cardiovascularly	Cardiovascularly	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
rhythm	rhythm	NN	I-NP	O
was	be	VBD	B-VP	O
regular	regular	JJ	B-NP	O
,	,	,	I-NP	O
tachycardiac	tachycardiac	JJ	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
1-2/6	1-2/6	CD	I-NP	O
systolic	systolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
apex	apex	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
abdomen	abdomen	NN	I-NP	O
was	be	VBD	B-VP	O
soft	soft	JJ	B-ADJP	O
,	,	,	O	O
,	,	,	O	O
nontender	nontender	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
nondistended	nondistended	JJ	B-ADJP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
bowel	bowel	NN	B-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
:	:	:	O	O
There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
nontender	nontender	NN	B-NP	O
.	.	.	O	O

Symmetric	Symmetric	JJ	B-NP	O
extremities	extremity	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
clubbing	clubbing	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
lives	live	VBZ	B-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
husband	husband	NN	I-NP	O
of	of	IN	B-PP	O
43	43	CD	B-NP	O
years	year	NNS	I-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
have	have	VBP	B-VP	O
no	no	DT	B-NP	O
children	child	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
used	use	VBN	I-VP	O
tobacco	tobacco	NN	B-NP	O
since	since	IN	B-PP	O
1984	1984	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
occasional	occasional	JJ	B-NP	O
alcohol	alcohol	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
notes	note	VBZ	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
drinks	drink	VBZ	B-VP	O
one	one	CD	B-NP	O
drink	drink	NN	I-NP	O
every	every	DT	B-NP	O
month	month	NN	I-NP	O
approximately	approximately	RB	B-ADVP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
outside	outside	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
labs	lab	NNS	I-NP	O
were	be	VBD	B-VP	O
as	as	IN	B-SBAR	O
follows	follow	VBZ	B-VP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
white	white	JJ	I-NP	O
count	count	NN	I-NP	O
was	be	VBD	B-VP	O
12	12	CD	B-NP	O
with	with	IN	B-PP	O
75	75	CD	B-NP	O
%	%	NN	I-NP	O
neutrophils	neutrophil	NNS	I-NP	O
,	,	,	O	O
3	3	CD	B-NP	O
eosinophils	eosinophil	NNS	I-NP	B-cell_type
,	,	,	O	O
and	and	CC	O	O
6-12	6-12	CD	B-NP	O
bands	band	NNS	I-NP	O
forms	form	NNS	I-NP	O
.	.	.	O	O

Hematocrit	Hematocrit	NN	B-NP	O
was	be	VBD	B-VP	O
45	45	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
platelet	platelet	NN	I-NP	O
count	count	NN	I-NP	O
was	be	VBD	B-VP	O
290	290	CD	B-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
PTT	PTT	NN	I-NP	O
was	be	VBD	B-VP	O
42	42	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
was	be	VBD	B-VP	O
2.2	2.2	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
Chem-7	Chem-7	NN	I-NP	B-protein
and	and	CC	O	O
her	her	PRP$	B-NP	O
sodium	sodium	NN	I-NP	O
was	be	VBD	B-VP	O
139	139	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
potassium	potassium	NN	I-NP	O
was	be	VBD	B-VP	O
4.5	4.5	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
chloride	chloride	NN	I-NP	O
101	101	CD	I-NP	O
and	and	CC	O	O
bicarbonate	bicarbonate	NN	B-NP	O
was	be	VBD	B-VP	O
31	31	CD	B-NP	O
and	and	CC	O	O
BUN	BUN	NN	B-NP	O
was	be	VBD	B-VP	O
20	20	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
creatine	creatine	NN	I-NP	O
was	be	VBD	B-VP	O
1.1	1.1	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
glucose	glucose	NN	I-NP	O
was	be	VBD	B-VP	O
118	118	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
total	total	JJ	I-NP	O
protein	protein	NN	I-NP	O
was	be	VBD	B-VP	O
7.7	7.7	CD	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
albumin	albumin	NN	I-NP	O
of	of	IN	B-PP	O
4.2	4.2	CD	B-NP	O
,	,	,	O	O
AST	AST	NN	B-NP	O
of	of	IN	B-PP	O
29	29	CD	B-NP	O
,	,	,	O	O
ALT	ALT	NN	B-NP	O
of	of	IN	B-PP	O
43	43	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
alkaline	alkaline	NN	B-NP	B-protein
phosphatase	phosphatase	NN	I-NP	I-protein
of	of	IN	B-PP	O
104	104	CD	B-NP	O
.	.	.	O	O

Total	Total	JJ	B-NP	O
bilirubin	bilirubin	NN	I-NP	O
is	be	VBZ	B-VP	O
0.3	0.3	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
pH	pH	NN	I-NP	O
was	be	VBD	B-VP	O
7.38	7.38	CD	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
carbon	carbon	NN	I-NP	O
dioxide	dioxide	NN	I-NP	O
of	of	IN	B-PP	O
54	54	CD	B-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
oxygen	oxygen	NN	I-NP	O
of	of	IN	B-PP	O
37	37	CD	B-NP	O
on	on	IN	B-PP	O
20	20	CD	B-NP	O
%	%	NN	I-NP	O
FiO2	FiO2	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
ambient	ambient	JJ	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
an	an	DT	B-NP	O
arterial	arterial	JJ	I-NP	O
blood	blood	NN	I-NP	O
gas	gas	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
EKG	EKG	NN	I-NP	B-protein
showed	show	VBD	B-VP	O
sinus	sinus	NN	B-NP	O
tachycardia	tachycardia	NN	I-NP	O
at	at	IN	B-PP	O
120	120	CD	B-NP	O
beats	beat	NNS	I-NP	O
per	per	IN	B-PP	O
minutes	minute	NNS	B-NP	O
.	.	.	O	O

QRS	QRS	NN	B-NP	B-protein
width	width	NN	I-NP	O
was	be	VBD	B-VP	O
approximately	approximately	RB	B-NP	O
120	120	CD	I-NP	O
milliseconds	millisecond	NNS	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
bundle	bundle	NN	I-NP	O
branch	branch	NN	I-NP	O
pattern	pattern	NN	I-NP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
axis	axis	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
left	left	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
by	by	IN	B-PP	O
voltage	voltage	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
1-2	1-2	CD	B-NP	O
mm	mm	NN	I-NP	O
ST-depression	ST-depression	NN	I-NP	O
in	in	IN	B-PP	O
2	2	CD	B-NP	O
,	,	,	I-NP	O
3	3	CD	I-NP	O
and	and	CC	O	O
AVF	AVF	NN	B-NP	B-protein
with	with	IN	B-PP	O
T-wave	T-wave	JJ	B-NP	O
inversions	inversion	NNS	I-NP	O
in	in	IN	B-PP	O
those	those	DT	B-NP	O
leads	lead	NNS	I-NP	O
,	,	,	O	O
also	also	RB	B-ADVP	O
T-wave	T-wave	VBP	B-VP	O
inversions	inversion	NNS	B-NP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
mm	mm	NN	I-NP	O
ST	ST	NN	I-NP	O
depression	depression	NN	I-NP	O
in	in	IN	B-PP	O
V5	V5	NN	B-NP	O
and	and	CC	I-NP	O
V6	V6	NN	I-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
only	only	JJ	I-NP	O
change	change	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
January	January	NNP	I-NP	O
,	,	,	O	O
2004	2004	CD	B-NP	O
,	,	,	O	O
EKG	EKG	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
T-wave	T-wave	NN	B-NP	O
inversion	inversion	NN	I-NP	O
in	in	IN	B-PP	O
V5	V5	NN	B-NP	O
,	,	,	O	O
otherwise	otherwise	RB	B-ADJP	O
stable	stable	JJ	I-ADJP	O
.	.	.	O	O

IMPRESSION	IMPRESSION	NN	B-NP	O
:	:	:	O	O
At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
60-year-old	60-year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
severe	severe	JJ	B-NP	O
COPD	COPD	NN	I-NP	O
and	and	CC	I-NP	O
CHF	CHF	NN	I-NP	B-protein
,	,	,	O	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
COPD	COPD	NN	I-NP	O
excerebration	excerebration	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
unlike	unlike	JJ	B-ADJP	O
many	many	JJ	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
previous	previous	JJ	I-NP	O
exacerbations	exacerbation	NNS	I-NP	O
in	in	IN	B-PP	O
that	that	IN	B-NP	O
she	she	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
experience	experience	VB	I-VP	O
any	any	DT	B-NP	O
upper	upper	JJ	I-NP	O
respiratory	respiratory	JJ	I-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
jugular	jugular	JJ	I-NP	O
venous	venous	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
,	,	,	O	O
so	so	IN	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
considered	consider	VBN	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
might	might	MD	B-VP	O
be	be	VB	I-VP	O
having	have	VBG	I-VP	O
a	a	DT	B-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
,	,	,	O	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

1	1	LS	B-LST	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
for	for	IN	B-PP	O
COPD	COPD	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
prednisone	prednisone	NN	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
each	each	DT	B-NP	O
morning	morning	NN	I-NP	O
,	,	,	O	O
Atrovent	Atrovent	NN	B-NP	O
and	and	CC	I-NP	O
albuterol	albuterol	NN	I-NP	O
nebulizers	nebulizer	NNS	I-NP	O
q.	q.	NN	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

and	and	CC	O	O
albuterol	albuterol	NN	B-NP	O
and	and	CC	O	O
Atrovent	Atrovent	JJ	B-NP	O
nebulizers	nebulizer	NNS	I-NP	O
as	as	IN	B-PP	O
needed	need	VBN	B-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
.	.	.	O	O

Initially	Initially	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
500	500	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
her	her	PRP$	B-NP	O
renal	renal	JJ	I-NP	O
function	function	NN	I-NP	O
worsened	worsen	VBD	B-VP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-PP	O
150	150	CD	B-NP	O
mg	mg	NN	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
and	and	CC	O	O
when	when	WRB	B-ADVP	O
her	her	PRP$	B-NP	O
renal	renal	JJ	I-NP	O
function	function	NN	I-NP	O
improved	improve	VBD	B-VP	O
again	again	RB	B-ADVP	O
her	her	PRP$	B-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
was	be	VBD	B-VP	O
once	once	RB	I-VP	O
again	again	RB	I-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-PP	O
500	500	CD	B-NP	O
mg	mg	NN	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
10-day	10-day	JJ	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
little	little	JJ	B-NP	O
concern	concern	NN	I-NP	O
for	for	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
embolism	embolism	NN	I-NP	O
,	,	,	O	O
given	give	VBN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
elevated	elevated	JJ	I-NP	O
INR	INR	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
decreased	decrease	VBN	I-NP	O
O2	O2	NN	I-NP	O
saturation	saturation	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
CO2	CO2	NN	I-NP	B-protein
was	be	VBD	B-VP	O
not	not	RB	O	O
very	very	RB	B-ADJP	O
elevated	elevated	JJ	I-ADJP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
outside	outside	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
D-dimer	D-dimer	NN	I-NP	B-protein
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
200	200	CD	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
negative	negative	JJ	B-ADJP	O
,	,	,	O	O
suggestive	suggestive	JJ	B-ADJP	O
very	very	RB	B-ADVP	O
highly	highly	RB	I-ADVP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
embolism	embolism	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
status	status	NN	I-NP	O
improved	improve	VBD	B-VP	O
throughout	throughout	IN	B-PP	O
her	her	PRP$	B-NP	O
stay	stay	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
by	by	IN	B-PP	O
May	May	NNP	B-NP	O
,	,	,	O	O
2004	2004	CD	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
sating	sate	VBG	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
90	90	CD	I-NP	O
%	%	NN	I-NP	O
range	range	NN	I-NP	O
on	on	IN	B-PP	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
nasal	nasal	JJ	B-NP	O
cannula	cannula	NN	I-NP	O
,	,	,	O	O
almost	almost	RB	B-ADVP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
physical	physical	JJ	I-NP	O
therapy	therapy	NN	I-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
would	would	MD	B-VP	O
benefit	benefit	VB	I-VP	O
from	from	IN	B-PP	O
further	further	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
rehabilitation	rehabilitation	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
this	this	DT	B-NP	O
dictation	dictation	NN	I-NP	O
is	be	VBZ	B-VP	O
being	be	VBG	I-VP	O
done	do	VBN	I-VP	O
,	,	,	O	O
the	the	DT	B-NP	O
plan	plan	NN	I-NP	O
is	be	VBZ	B-VP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
either	either	CC	I-NP	O
to	to	TO	B-VP	O
go	go	VB	I-VP	O
to	to	TO	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
rehabilitation	rehabilitation	NN	I-NP	O
or	or	CC	O	O
to	to	TO	B-VP	O
stay	stay	VB	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
until	until	IN	B-SBAR	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
fully	fully	RB	B-ADJP	O
ready	ready	JJ	I-ADJP	O
and	and	CC	I-ADJP	O
safe	safe	JJ	I-ADJP	O
to	to	TO	B-VP	O
go	go	VB	I-VP	O
home	home	NN	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
at	at	IN	B-PP	O
an	an	DT	B-NP	O
increased	increase	VBN	I-NP	O
fall	fall	NN	I-NP	O
risk	risk	NN	I-NP	O
given	give	VBN	B-VP	O
her	her	PRP$	B-NP	O
severe	severe	JJ	I-NP	O
osteoporosis	osteoporosis	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Cardiovascular	Cardiovascular	NNP	B-NP	O
:	:	:	O	O
A.	A.	NNP	B-NP	O
Pump	Pump	NNP	I-NP	O
:	:	:	O	O
Initially	Initially	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	B-VP	O
possibly	possibly	RB	I-VP	O
be	be	VB	I-VP	O
volume	volume	NN	B-NP	O
overloaded	overload	VBD	B-VP	O
given	give	VBN	I-VP	O
the	the	DT	B-NP	O
fact	fact	NN	I-NP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
taking	take	VBG	I-VP	O
her	her	PRP$	B-NP	O
Lasix	Lasix	NN	I-NP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
her	her	PRP$	B-NP	O
JVP	JVP	NN	I-NP	B-protein
appeared	appear	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
some	some	DT	B-NP	O
question	question	NN	I-NP	O
whether	whether	IN	B-SBAR	O
she	she	PRP	B-NP	O
might	might	MD	B-VP	O
has	have	VBZ	I-VP	O
been	be	VBN	I-VP	O
having	have	VBG	I-VP	O
increasing	increase	VBG	I-VP	O
paroxysmal	paroxysmal	JJ	B-NP	O
nocturnal	nocturnal	JJ	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
or	or	CC	O	O
at	at	IN	B-ADVP	O
least	least	JJS	I-ADVP	O
orthopnea	orthopnea	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
diuresed	diurese	VBN	I-VP	O
aggressively	aggressively	RB	B-ADVP	O
with	with	IN	B-PP	O
60	60	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
IV	IV	NNP	B-NP	O
Lasix	Lasix	NNP	I-NP	O
,	,	,	O	O
two	two	CD	B-NP	O
times	time	NNS	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
lab	lab	NN	B-NP	O
results	result	NNS	I-NP	O
suggested	suggest	VBD	B-VP	O
that	that	IN	B-SBAR	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
part	part	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
presentation	presentation	NN	I-NP	O
.	.	.	O	O

First	First	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
brain	brain	NN	I-NP	O
natriuretic	natriuretic	JJ	I-NP	O
peptide	peptide	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
,	,	,	O	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
value	value	NN	I-NP	O
of	of	IN	B-PP	O
proximally	proximally	RB	B-NP	O
134	134	CD	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
approximately	approximately	RB	B-ADVP	O
a	a	DT	B-NP	O
baseline	baseline	NN	I-NP	O
of	of	IN	B-PP	O
141	141	CD	B-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
having	have	VBG	I-VP	O
an	an	DT	B-NP	O
acute	acute	JJ	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
creatinine	creatinine	NN	I-NP	O
increased	increase	VBD	B-VP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
outside	outside	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
value	value	NN	I-NP	O
of	of	IN	B-PP	O
1.0	1.0	CD	B-NP	O
.	.	.	O	O

When	When	WRB	B-ADVP	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
first	first	RB	I-VP	O
checked	check	VBN	I-VP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
on	on	IN	B-PP	O
January	January	NNP	B-NP	O
,	,	,	O	O
2004	2004	CD	B-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
Clinchau	Clinchau	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
1.7	1.7	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
received	receive	VBD	B-VP	O
her	her	PRP	B-NP	O
two	two	CD	I-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
,	,	,	O	O
one	one	CD	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
night	night	NN	I-NP	O
of	of	IN	B-PP	O
November	November	NNP	B-NP	O
,	,	,	O	O
2004	2004	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
then	then	RB	B-ADVP	O
again	again	RB	I-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
of	of	IN	B-PP	O
January	January	NNP	B-NP	O
,	,	,	O	O
2004	2004	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
afternoon	afternoon	NN	I-NP	O
of	of	IN	B-PP	O
March	March	NNP	B-NP	O
,	,	,	O	O
2004	2004	CD	B-NP	O
,	,	,	O	O
increased	increase	VBN	B-VP	O
to	to	TO	B-PP	O
2.2	2.2	CD	B-NP	O
.	.	.	O	O

Urine	Urine	NN	B-NP	O
electrolytes	electrolyte	NNS	I-NP	O
were	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
acute	acute	JJ	I-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
workup	workup	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discussed	discuss	VBN	I-VP	O
below	below	IN	B-PP	O
under	under	IN	B-PP	O
the	the	DT	B-NP	O
renal	renal	JJ	I-NP	O
section	section	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
IV	IV	CD	B-NP	O
fluids	fluid	NNS	I-NP	O
and	and	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
any	any	DT	B-NP	O
further	further	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
of	of	IN	B-PP	O
heart	heart	NN	B-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
normal	normal	JJ	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
40	40	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
p.o.	p.o.	FW	I-NP	O
every	every	DT	B-NP	O
morning	morning	NN	I-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
September	September	NNP	B-NP	O
,	,	,	O	O
2004	2004	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
that	that	DT	B-NP	O
dose	dose	NN	I-NP	O
.	.	.	O	O

B.	B.	NNP	B-NP	O
Rhythm	Rhythm	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
monitored	monitor	VBN	I-VP	O
on	on	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
and	and	CC	B-PP	O
after	after	IN	B-PP	O
her	her	PRP$	B-NP	O
sinus	sinus	NN	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
her	her	PRP$	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
came	come	VBD	B-VP	O
down	down	RB	B-ADVP	O
as	as	IN	B-PP	O
her	her	PRP$	B-NP	O
hyperoxemia	hyperoxemia	NN	I-NP	O
improved	improve	VBD	B-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
issues	issue	NNS	I-NP	O
.	.	.	O	O

C.	C.	NNP	B-NP	O
Ischemia	Ischemia	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
HMG-COA	HMG-COA	NN	I-NP	B-protein
reductase	reductase	NN	I-NP	I-protein
inhibitor	inhibitor	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
folic	folic	JJ	I-NP	O
acid	acid	NN	I-NP	O
,	,	,	O	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
put	put	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
beta-blocker	beta-blocker	NN	I-NP	O
given	give	VBN	B-VP	O
her	her	PRP$	B-NP	O
bronchospastic	bronchospastic	JJ	I-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
,	,	,	O	O
but	but	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
angiotensin	angiotensin	NN	I-NP	O
receptor	receptor	NN	I-NP	O
blocker	blocker	NN	I-NP	O
after	after	IN	B-PP	O
her	her	PRP$	B-NP	O
acute	acute	JJ	I-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
resolved	resolve	VBN	B-VP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
1.0	1.0	CD	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
outside	outside	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
and	and	CC	O	O
1.71	1.71	CD	B-NP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
first	first	RB	B-ADVP	O
presented	present	VBD	B-VP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
is	be	VBZ	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
low	low	JJ	I-NP	O
1	1	CD	I-NP	O
's	's	POS	B-NP	O
;	;	:	O	O
1.0-1	1.0-1	CD	B-NP	O
.5	.5	CD	I-NP	O
as	as	IN	B-PP	O
her	her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
peak	peak	JJ	I-NP	O
creatinine	creatinine	NN	I-NP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
stay	stay	NN	I-NP	O
was	be	VBD	B-VP	O
January	January	NNP	B-NP	O
,	,	,	O	O
2004	2004	CD	B-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
5	5	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
p.m.	p.m.	RB	I-NP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
2.2	2.2	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
BUN	BUN	NN	I-NP	B-protein
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
was	be	VBD	B-VP	O
55	55	CD	B-NP	O
.	.	.	O	O

Urine	Urine	NN	B-NP	O
electrolytes	electrolyte	NNS	I-NP	O
were	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
urine	urine	NN	I-NP	O
sodium	sodium	NN	I-NP	O
of	of	IN	B-PP	O
39	39	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
creatinine	creatinine	NN	B-NP	O
of	of	IN	B-PP	O
137	137	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
that	that	DT	B-NP	O
was	be	VBD	B-VP	O
only	only	RB	B-NP	O
12	12	CD	I-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
got	get	VBD	B-VP	O
her	her	PRP$	B-NP	O
last	last	JJ	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
prerenal	prerenal	JJ	B-NP	O
azotemia	azotemia	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
IV	IV	CD	B-NP	O
fluids	fluid	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
improved	improve	VBD	B-VP	O
,	,	,	O	O
and	and	CC	O	O
on	on	IN	B-PP	O
May	May	NNP	B-NP	O
,	,	,	O	O
2004	2004	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
1.3	1.3	CD	B-NP	O
,	,	,	O	O
approximately	approximately	RB	B-ADVP	O
her	her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
BUN	BUN	NN	I-NP	B-protein
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
was	be	VBD	B-VP	O
30	30	CD	B-NP	O
,	,	,	O	O
increased	increase	VBD	B-VP	O
from	from	IN	B-PP	O
23	23	CD	B-NP	O
on	on	IN	B-PP	O
April	April	NNP	B-NP	O
,	,	,	O	O
2004	2004	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
monitored	monitor	VBN	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
to	to	TO	B-VP	O
make	make	VB	I-VP	O
sure	sure	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
her	her	PRP$	B-NP	O
Lasix	Lasix	NN	I-NP	O
dose	dose	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
too	too	RB	B-ADJP	O
high	high	JJ	I-ADJP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Musculoskeletal	Musculoskeletal	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
creatine	creatine	NN	I-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
was	be	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
to	to	TO	B-PP	O
574	574	CD	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
rechecked	rechecke	VBN	I-VP	O
on	on	IN	B-PP	O
April	April	NNP	B-NP	O
,	,	,	O	O
2004	2004	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
1967	1967	CD	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
two	two	CD	B-NP	O
factors	factor	NNS	I-NP	O
.	.	.	O	O

Increased	Increase	VBN	B-NP	O
release	release	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
muscle	muscle	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
MB-fraction	MB-fraction	NN	I-NP	O
was	be	VBD	B-VP	O
only	only	RB	B-NP	O
33.5	33.5	CD	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
5	5	CD	I-NP	O
%	%	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
troponin	troponin	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

So	So	RB	B-NP	O
this	this	DT	I-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
increased	increase	VBN	I-NP	O
work	work	NN	I-NP	O
of	of	IN	B-PP	O
breathing	breathing	NN	B-NP	O
and	and	CC	I-NP	O
release	release	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
muscle	muscle	NN	I-NP	O
and	and	CC	O	O
exacerbated	exacerbate	VBN	B-VP	O
by	by	IN	B-PP	O
her	her	PRP	B-NP	O
acute	acute	JJ	I-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
and	and	CC	I-NP	O
retention	retention	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
creatine	creatine	NN	I-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
.	.	.	O	O

Her	Her	PRP$	B-NP	O
creatine	creatine	NN	I-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
decreased	decrease	VBD	B-VP	O
by	by	IN	B-PP	O
July	July	NNP	B-NP	O
,	,	,	O	O
2004	2004	CD	B-NP	O
,	,	,	O	O
to	to	TO	B-PP	O
1195	1195	CD	B-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
felt	felt	VB	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
rhabdomyolysis	rhabdomyolysis	NN	B-NP	O
causing	cause	VBG	B-VP	O
renal	renal	JJ	B-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
rather	rather	RB	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
causing	cause	VBG	B-VP	O
retention	retention	NN	B-NP	O
of	of	IN	B-PP	O
creatine	creatine	NN	B-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
disease	disease	NN	I-NP	O
from	from	IN	B-PP	O
increased	increase	VBN	B-NP	O
work	work	NN	I-NP	O
of	of	IN	B-PP	O
breathing	breathing	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Hematology	Hematology	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
INR	INR	NN	I-NP	B-protein
throughout	throughout	IN	B-PP	O
her	her	PRP$	B-NP	O
stay	stay	NN	I-NP	O
remained	remain	VBD	B-VP	O
therapeutic	therapeutic	JJ	B-ADJP	O
between	between	IN	B-PP	O
2.4	2.4	CD	B-NP	O
and	and	CC	I-NP	O
2.6	2.6	CD	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
May	May	NNP	B-NP	O
,	,	,	O	O
2004	2004	CD	B-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
2.5	2.5	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
was	be	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
at	at	IN	B-PP	O
admission	admission	NN	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
outside	outside	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
shift	shift	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
and	and	CC	I-NP	O
steroids	steroid	NNS	I-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-VP	O
interpret	interpret	VB	I-VP	O
her	her	PRP$	B-NP	O
white	white	JJ	I-NP	O
count	count	NN	I-NP	O
deferential	deferential	JJ	B-ADJP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
white	white	JJ	I-NP	O
count	count	NN	I-NP	O
remained	remain	VBD	B-VP	O
elevated	elevated	JJ	B-ADJP	O
between	between	IN	B-PP	O
15	15	CD	B-NP	O
and	and	CC	I-NP	O
20	20	CD	I-NP	O
throughout	throughout	IN	B-PP	O
her	her	PRP$	B-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
neutrophil	neutrophil	NN	I-NP	B-cell_type
count	count	NN	I-NP	O
remained	remain	VBD	B-VP	O
between	between	IN	B-PP	O
70	70	CD	B-NP	O
and	and	CC	I-NP	O
78	78	CD	I-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
that	that	DT	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
urinalysis	urinalysis	NN	I-NP	O
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
,	,	,	O	O
which	which	WDT	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
suggest	suggest	VB	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
urinary	urinary	JJ	I-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
TSH	TSH	NN	I-NP	O
was	be	VBD	B-VP	O
0.46	0.46	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
T4	T4	NN	I-NP	O
of	of	IN	B-PP	O
7.8	7.8	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
up	up	RP	B-PRT	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
this	this	DT	B-NP	O
may	may	MD	B-VP	O
represent	represent	VB	I-VP	O
subclinical	subclinical	JJ	B-NP	O
hyperthyroidism	hyperthyroidism	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
thyroid	thyroid	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
osteoporosis	osteoporosis	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
calcium	calcium	NN	B-NP	O
carbonate	carbonate	NN	I-NP	O
,	,	,	O	O
vitamin	vitamin	NN	B-NP	O
D	D	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Fosamax	Fosamax	NN	B-NP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Rheumatology	Rheumatology	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
probenecid	probenecid	NN	I-NP	O
250	250	CD	I-NP	O
mg	mg	NN	I-NP	O
two	two	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
symptoms	symptom	NNS	I-NP	O
of	of	IN	B-PP	O
gout	gout	NN	B-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Psychiatry	Psychiatry	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
clonazepam	clonazepam	NN	I-NP	O
and	and	CC	I-NP	O
Celexa	Celexa	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
Ritalin	Ritalin	NN	B-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
Ritalin	Ritalin	NN	I-NP	B-protein
given	give	VBN	B-PP	O
her	her	PRP$	B-NP	O
tachycardia	tachycardia	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
feel	feel	VB	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
Ritalin	Ritalin	NN	I-NP	B-protein
was	be	VBD	B-VP	O
helping	help	VBG	I-VP	O
her	her	PRP	B-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Pain	Pain	NNP	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
Vioxx	Vioxx	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
her	her	PRP$	B-NP	O
renal	renal	JJ	I-NP	O
issues	issue	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
will	will	MD	B-VP	O
also	also	RB	I-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
discharge	discharge	NN	I-NP	O
medications	medication	NNS	I-NP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
reassessed	reassess	VBN	I-VP	O
by	by	IN	B-PP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
doctor	doctor	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
benefits	benefit	NNS	I-NP	O
may	may	MD	B-VP	O
outweigh	outweigh	VB	I-VP	O
the	the	DT	B-NP	O
risks	risk	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
this	this	DT	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
up	up	RB	B-ADVP	O
to	to	TO	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Satterfield	Satterfield	NNP	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
long-term	long-term	JJ	I-NP	O
relationship	relationship	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Infectious	Infectious	JJ	B-NP	O
disease	disease	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
blood	blood	NN	B-NP	O
cultures	culture	NNS	I-NP	O
sent	send	VBN	B-VP	O
,	,	,	O	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

At	At	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
urinalysis	urinalysis	NN	I-NP	O
showed	show	VBD	B-VP	O
many	many	JJ	B-NP	O
red	red	JJ	I-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

It	It	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
some	some	DT	B-NP	O
white	white	JJ	I-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
leucocyte	leucocyte	NN	B-NP	B-protein
esterase	esterase	NN	I-NP	I-protein
.	.	.	O	O

This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
most	most	RBS	B-ADVP	O
likely	likely	RB	I-ADVP	O
just	just	RB	B-ADVP	O
because	because	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
bleeding	bleeding	JJ	B-NP	O
,	,	,	I-NP	O
secondary	secondary	JJ	I-NP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
Foley	Foley	NNP	I-NP	O
catheter	catheter	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
use	use	VBP	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
discharge	discharge	NN	I-NP	O
sheet	sheet	NN	I-NP	O
for	for	IN	B-PP	O
discharge	discharge	NN	B-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
1-0714061	1-0714061	CD	B-NP	O
EMSSten	EMSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
BARUS	BARUS	NNP	B-NP	O
,	,	,	O	O
BERNARD	BERNARD	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
WULFF	WULFF	NNP	B-NP	O
,	,	,	O	O
THADDEUS	THADDEUS	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
6384681	6384681	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
1/9/04	1/9/04	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
1/9/04	1/9/04	CD	B-NP	O

